NFE2L2 and neoplasm: The approach mechanistically inhibited the proliferation of BC cells MDA-MB-231 in vitro, downregulated the expression of Nrf2 and its downstream genes HO-1 and NQO1, and promoted ROS production and accumulation in these tumor cells.